Teleretinal Services

The ifa group of companies, represented by Inoveon Corp, is the proven expert in detection, staging, and monitoring of diabetic retinopathy and macular edema. Built on its patented DR3DT™ system, Inoveon helps group practices create and manage a completely turnkey on-site system. The benefit is that physician groups, in a variety of settings, can easily implement the “gold standard” quality of care developed by the National Institutes of Health, and used in clinical trials like the Diabetes Control and Complications Trial (DCCT), into the day-to-day practice in their own clinics.

Resource Center